ArticleFrontiers in psychiatry2025
Three-dimensional facial features of suicide risk in females with depression.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Suicide is the most severe consequence of Major Depressive Disorder (MDD). Current risk assessments rely heavily on subjective self-reports, which lack reliability. Emerging technologies, such as facial and behavioral recognition devices, are being explored to improve suicide risk evaluation. This study aimed to examine the potential of 3D facial features in identifying suicide risk and uncovering sex-specific characteristics in patients with MDD. Methods: We conducted a cross-sectional study involving 222 MDD patients. Suicide-related information was collected from caregivers, while independent raters assessed depressive symptoms and recorded sociodemographic data. Three-dimensional facial scans were acquired using the 3dMDface System, followed by preprocessing to extract key facial landmarks. Sex-stratified subgroup analyses were performed to identify suicide risk-associated facial features. Logistic regression analysis was used to evaluate predictors, including demographic data, clinical characteristics, and the identified facial markers. Results: Data from 203 patients were analyzed, including 110 in the suicide-risk group and 93 in the non-suicidal group. The suicidal group exhibited significantly shorter philtrum length (t = 2.137, Conclusion: This study identified sex-specific facial features associated with suicide risk in MDD, with reduced philtrum depth in females emerging as a correlate. These objective measures could complement current clinical risk assessments, though further longitudinal validation is required. Clinical trial registration: https://www.chictr.org.cn, identifier ChiCTR2400090458.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.